These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 16265534)

  • 1. Therapy insight: cardiovascular complications associated with muscular dystrophies.
    McNally EM; MacLeod H
    Nat Clin Pract Cardiovasc Med; 2005 Jun; 2(6):301-8. PubMed ID: 16265534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dystrophies and heart disease.
    Cox GF; Kunkel LM
    Curr Opin Cardiol; 1997 May; 12(3):329-43. PubMed ID: 9243091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follow-up of three patients with a large in-frame deletion of exons 45-55 in the Duchenne muscular dystrophy (DMD) gene.
    Nakamura A; Yoshida K; Fukushima K; Ueda H; Urasawa N; Koyama J; Yazaki Y; Yazaki M; Sakai T; Haruta S; Takeda S; Ikeda S
    J Clin Neurosci; 2008 Jul; 15(7):757-63. PubMed ID: 18261911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic background influences muscular dystrophy.
    Heydemann A; Huber JM; Demonbreun A; Hadhazy M; McNally EM
    Neuromuscul Disord; 2005 Oct; 15(9-10):601-9. PubMed ID: 16084087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient page. Gene therapy and muscular dystrophies.
    Karceski S
    Neurology; 2008 Jul; 71(4):e6-8. PubMed ID: 18645160
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhancement of plasmid-mediated gene therapy for muscular dystrophy by directed plasmid integration.
    Bertoni C; Jarrahian S; Wheeler TM; Li Y; Olivares EC; Calos MP; Rando TA
    Proc Natl Acad Sci U S A; 2006 Jan; 103(2):419-24. PubMed ID: 16387861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcoglycans take center stage in gene transfer therapy.
    Müller OJ; Lochmüller H
    Neurology; 2008 Jul; 71(4):234-5. PubMed ID: 18525030
    [No Abstract]   [Full Text] [Related]  

  • 8. Consequences of disrupting the dystrophin-sarcoglycan complex in cardiac and skeletal myopathy.
    Heydemann A; McNally EM
    Trends Cardiovasc Med; 2007 Feb; 17(2):55-9. PubMed ID: 17292047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac involvement in Emery-Dreifuss muscular dystrophy.
    Wessely R; Seidl S; Schömig A
    Clin Genet; 2005 Mar; 67(3):220-3. PubMed ID: 15691357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inherited myopathies and muscular dystrophies.
    Cardamone M; Darras BT; Ryan MM
    Semin Neurol; 2008 Apr; 28(2):250-9. PubMed ID: 18351526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Conduction defects and arrhythmias in peripheral myopathies].
    Fauchier L; Babuty D; Pellieux S; Toutain A; Cosnay P
    Arch Mal Coeur Vaiss; 2004 Dec; 97 Spec No 4(4):25-33. PubMed ID: 15714887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal manifestations of the muscular dystrophies.
    Nowak TV; Ionasescu V; Anuras S
    Gastroenterology; 1982 Apr; 82(4):800-10. PubMed ID: 7037523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac involvement in muscular dystrophies.
    Beynon RP; Ray SG
    QJM; 2008 May; 101(5):337-44. PubMed ID: 18238819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy for muscular dystrophy: current progress and future prospects.
    Trollet C; Athanasopoulos T; Popplewell L; Malerba A; Dickson G
    Expert Opin Biol Ther; 2009 Jul; 9(7):849-66. PubMed ID: 19527108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac monitoring and treatment for children and adolescents with neuromuscular disorders.
    English KM; Gibbs JL
    Dev Med Child Neurol; 2006 Mar; 48(3):231-5. PubMed ID: 16483403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics.
    van Tintelen JP; Hofstra RM; Katerberg H; Rossenbacker T; Wiesfeld AC; du Marchie Sarvaas GJ; Wilde AA; van Langen IM; Nannenberg EA; van der Kooi AJ; Kraak M; van Gelder IC; van Veldhuisen DJ; Vos Y; van den Berg MP;
    Am Heart J; 2007 Dec; 154(6):1130-9. PubMed ID: 18035086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of dystrophin and utrophin staining in childhood muscular dystrophy.
    Sundaram C; Vydehi B; Meena K; Murthy J
    Indian J Pathol Microbiol; 2004 Jul; 47(3):367-9. PubMed ID: 16295426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac involvement in muscular dystrophy: advances in diagnosis and therapy.
    Yilmaz A; Sechtem U
    Heart; 2012 Mar; 98(5):420-9. PubMed ID: 22311853
    [No Abstract]   [Full Text] [Related]  

  • 19. [Fukuyama congenital muscular dystrophy and related alpha-dystroglycanopathies].
    Murakami T; Nishino I
    Brain Nerve; 2008 Oct; 60(10):1159-64. PubMed ID: 18975603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dystrophinopathy carrier determination and detection of protein deficiencies in muscular dystrophy using lentiviral MyoD-forced myogenesis.
    Cooper ST; Kizana E; Yates JD; Lo HP; Yang N; Wu ZH; Alexander IE; North KN
    Neuromuscul Disord; 2007 Apr; 17(4):276-84. PubMed ID: 17303423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.